Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Corporate Executive VP & CCO | November 07, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date November 07, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 23,337 |
Reported balance
After 2024-11-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-11-07 · Gift · Disposed 470 · Balance 23,337 F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust. |
| Common StockSEC Table I · non-derivative | Direct | 2,468 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,468 |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.35 | $14,135.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 26 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,423 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 102 | $141.32 | $14,414.64 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 25 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,523 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 830 | $141.31 | $117,287.30 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 24 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,625 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $141.31 | $4,239.15 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 23 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,455 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 30 | $141.29 | $4,238.55 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 22 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,485 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $141.28 | $14,127.50 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 21 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,515 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.26 | $28,252.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 20 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,615 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 43 | $141.24 | $6,073.32 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 19 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,815 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.19 | $28,238.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 18 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,858 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.18 | $28,236.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 17 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,058 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5 | $141.16 | $705.78 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 16 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,258 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $141.15 | $28,230.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 15 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,263 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $140.98 | $42,294.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 14 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,463 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $140.97 | $42,291.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,763 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.96 | $28,192.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,063 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.94 | $14,094.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,263 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 308 | $140.93 | $43,406.44 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,363 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 210 | $140.92 | $29,593.20 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,671 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,000 | $140.91 | $140,910.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,881 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.90 | $56,360.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,881 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 900 | $140.87 | $126,783.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 6 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,281 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $140.86 | $28,172.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 5 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,181 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 575 | $140.85 | $80,988.75 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 4 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,381 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.84 | $56,336.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 3 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,956 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.83 | $56,330.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 2 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,356 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.82 | $14,082.00 |
DisclosureSEC source: 0001127602-19-009095 · form4.xml · nonDerivative · entry 1 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,756 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $140.82 | $1,408.15 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 30 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,856 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 112 | $140.81 | $15,770.72 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 29 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,866 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.80 | $14,080.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 28 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,978 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.80 | $14,079.50 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 27 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,078 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $140.79 | $112,632.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 26 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,178 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.78 | $14,078.25 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 25 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,978 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 230 | $140.78 | $32,379.40 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 24 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,078 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $140.78 | $70,387.50 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 23 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,308 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $140.77 | $42,231.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 22 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,808 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $140.76 | $56,304.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 21 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,108 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 404 | $140.75 | $56,863.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 20 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,508 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.74 | $14,074.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 19 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,912 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $140.73 | $42,219.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 18 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,012 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 530 | $140.72 | $74,581.60 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 17 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,312 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $140.71 | $70,355.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 16 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,842 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 539 | $140.70 | $75,837.30 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 15 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,342 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 59 | $140.69 | $8,300.71 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 14 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,881 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 515 | $140.69 | $72,452.78 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 13 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,940 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 406 | $140.68 | $57,116.08 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 12 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,455 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $140.68 | $14,067.50 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 11 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,861 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,100 | $140.67 | $154,737.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 10 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,961 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 800 | $140.66 | $112,528.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 9 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,061 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,300 | $140.65 | $182,845.00 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 8 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,861 Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:06 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5 | $140.64 | $703.20 |
DisclosureSEC source: 0001127602-19-009093 · form4.xml · nonDerivative · entry 7 Barbo William D · CIK 0001688104 · Corporate Executive VP & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,161 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.